Pharmacology-based ranking of anti-cancer drugs to guide clinical development of cancer immunotherapy combinations.
Saved in:
| Title: | Pharmacology-based ranking of anti-cancer drugs to guide clinical development of cancer immunotherapy combinations. |
|---|---|
| Authors: | Lemaire V; Department of Clinical Pharmacology, Genentech Inc, 1 DNA Way, South San Francisco, CA, 94080, USA. lemaire.vincent@gene.com., Shemesh CS; Department of Clinical Pharmacology, Genentech Inc, 1 DNA Way, South San Francisco, CA, 94080, USA. shemesh.colby@gene.com., Rotte A; Independent Consultant, Santa Clara, USA.; Current address: Clinical and Regulatory Affairs, Arcellx, Gaithersburg, USA. |
| Source: | Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2021 Oct 01; Vol. 40 (1), pp. 311. Date of Electronic Publication: 2021 Oct 01. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1756-9966 |
|---|---|
| DOI: | 10.1186/s13046-021-02111-5 |
